Actively Recruiting
Evaluating the 30-Day WILD 5 Wellness Program for Adults Using GLP-1 or Dual GIPGLP-1 Medications Supporting Physical and Emotional Well-Being
Led by Saundra Jain · Updated on 2026-09-03
200
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether a 30-day structured wellness program can improve physical and emotional well-being in adults who are already taking a GLP-1 or dual GIPGLP-1 medication for an FDA-approved use. The study aims to understand changes in mood, anxiety, functioning, mindfulness, self-compassion, eating behaviors, pain, and overall wellness after completing the program. This research focuses on the wellness program itself and does not change the participants medication. Participants will follow the WILD 5 Wellness program for 30 days, which includes daily practices in exercise, mindfulness, sleep, social connection, and nutrition. They will complete the program independently and fill out a brief online tracking form every day during the program. This single-group study observes participants as they engage in the wellness activities without altering their current medication. During the study, participants will complete online questionnaires before starting and after finishing the 30-day program to measure changes in well-being using several scales such as the HERO Wellness Scale and others assessing mood, anxiety, pain, sleep, and social connection. The research team will monitor these changes to understand the programs impact. The total participation lasts for about one month, with daily tracking and assessments at the beginning and end.
CONDITIONS
Brief Title
The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness
Research Team
S
Saundra Jain, MA, PsyD, LPC
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here